Insmed Incorporated Share Price Today: Live Updates & Key Insights
Insmed Incorporated share price today is $136.87, up -5.56%. The stock opened at $142.39 against the previous close of $144, with an intraday high of $143.19 and low of $135.82.
Insmed Incorporated Share Price Chart
Insmed Incorporated
Insmed Incorporated Share Price Performance
Insmed Incorporated Institutional Holdings
Insmed Incorporated Market Status
Insmed Incorporated Fundamentals
Market Cap 29315.06 M
PB Ratio 42.0034
PE Ratio 0.0
Enterprise Value 30196.10 M
Total Assets 2264.56 M
Volume 4561590
Insmed Incorporated Company Financials
About Insmed Incorporated & investment objective
Company Information Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of refractory nontuberculous mycobacterial lung infections, as well as is in phase 3 clinical trial for the treatment of mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It also develops brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1(DPP1) that is in phase 3 clinical trial for the treatment of bronchiectasis; and in phase 2 clinical trial for the treatment of chronic rhinosinusitis without nasal polyps and hidradenitis suppurativa. In addition, the company is developing treprostinil palmitil inhalation powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil, which is in phase 3 clinical trial for the treatment of pulmonary hypertension associated with interstitial lung disease; and phase 2 clinical trial for the treatment of pulmonary arterial hypertension. Further, it develops INS1201, a microdystrophin adeno-associated virus gene replacement therapy which is in phase 1 clinical trial for the treatment of Duchenne muscular dystrophy, as well as it is also developing pre-clinical research programs for gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. In addition, it provides INS1148, monoclonal antibody targeting stem cell factor called SCF248 that is in phase-2 clinical trial for the treatment of interstitial lung disease, and asthma; and INS1202, an intrathecally delivered gene therapy which is in phase 1 of clinical trial for the treatment of amyotrophic lateral sclerosis. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Organisation Biotechnology
Employees 1664
Industry Biotechnology
CEO Mr. William H. Lewis J.D., M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Insmed Incorporated FAQs
What is the share price of Insmed Incorporated today?
The current share price of Insmed Incorporated is $136.87.
Can I buy Insmed Incorporated shares in India?
Yes, Indian investors can buy Insmed Incorporated shares by opening an international trading and demat account with Motilal Oswal.
How to buy Insmed Incorporated shares in India?
You can easily invest in Insmed Incorporated shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Insmed Incorporated shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Insmed Incorporated.
Can I buy fractional shares of Insmed Incorporated?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Insmed Incorporated?
Insmed Incorporated has a market cap of $29315.06 M.
In which sector does Insmed Incorporated belong?
Insmed Incorporated operates in the Biotechnology sector.
What documents are required to invest in Insmed Incorporated stocks?
To invest, you typically need:
What is the PE and PB ratio of Insmed Incorporated?
The PE ratio of Insmed Incorporated is N/A and the PB ratio is 42.00.